Abstract:Background: Dehydroepiandrosterone (DHEA) derived from adrenal cortex has an indirect bioeffect through differentiating into androgen or estrogen in the related peripheral tissues. Objective: To verify the effects and mechanisms of DHEA on promoting osteoblasts (OBs) proliferation. Design, time and setting: The grouping controlled experiment was accomplished in Shanghai Sixth People's Hospital affiliated to Shanghai Jiao Tong University and Institute of Radiation Medicine, Fudan University from January 2006 to February 2007. Materials: Ten SD rats were recruited, 1 day old, regardless of gender. DHEA was the product of American Sigma Company. Methods: Rat OBs were separated and cultured in vitro. First generation of OBs cultured in a varied concentrations of DHEA (1 × 10-5, 1 × 10-7 and 1 × 10-9 mmol/L) for 72 hours were set up as the experiment group, while those exposed to 1 × 10-8 mmol/L of estradiol culture were regarded as positive controls and blank control group was set up as well. Main outcome measures: The OBs were identified by cell morphology and alkaline phosphatase (ALP) dyeing. Light microscope and methyl thiazolyl tetrazolium assay were used to detect the growth and proliferation of OBs. The formation of mineralized nodus was examined by alizarin bordeaux stain. The concentrations of osteoprotegerin in DHEA culture solution were also measured by double antibody sandwich ABC-ELISA simultaneously. Results: 1 Identification of primarily cultured OBs showed ALP dyeing was positive. 2 Proliferation rate of OBs was increased in experiment groups compared with that of the blank control group, and the most significant increase occurred in the concentration of 1 × 10-7 mmol/ L DHEA culture (P < 0.01). However, there was no significant difference in proliferation rate between estradiol culture and DHEA group (P > 0.05). 3 ALP activity in experiment groups was higher, especially in the group with the concentration of 1 × 10-7 nmol/L DHEA (P < 0.01). No significant differences were seen in the ALP activity between estradiol culture and DHEA groups with concentration of 1 × 10-7 and 1 × 10-9 mmol/L (P > 0.05). 4 ALP activity of unitary cell population was higher in 1 × 10-9 mmol/L DHEA culture group than that in blank control group (P < 0.05). 5 Both the area and area ratio of mineralized nodules were significantly increased in various concentrations of DHEA groups (P < 0.01), which was similar to that of estradiol culture. 6 Responds of osteoprotegerin to DHEA were the most active in 1 × 10-9 mmol/L DHEA group after 72 hours of the culture (P < 0.01), and had a positive correlation with OBs proliferation. Conclusion: DHEA may promote growth and proliferation of rat OBs, its effect at the optimal concentration of 1 × (10-7 - 10-9) mmol/L is identical with estradiol, and might be related to stimulating osteoprotegerin pathway DHEA at the concentration exceeding 1 × 10-5 mmol/L has no effect on OBs proliferation.

A study on the effect of using different dosage of DMPA on bone metabolism

The Study on the Effect of Using Depo Medroxyprogesterone Acetate for Contraception on Bone Metabolism

Clinical research of long acting contraception of DMPA on bone metabolism

Exploratory study of the effect of lifestyle counselling on bone mineral density and body composition in users of the contraceptive depot-medroxyprogesterone acetate

The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women

Forearm bone density in users of Depo-Provera as a contraceptive method

Application of Depot Medroxyprogesterone Acetate in Breast-Feeding Women

Body composition, resting energy expenditure and inflammatory markers: impact in users of depot medroxyprogesterone acetate after 12 months follow-up

Effect of gonadotropin-releasing hormone agonist and medroxyprogesterone acetate on calcium metabolism: a prospective, randomized, double-blind, placebo-controlled, crossover trial

Concentration Changes of Medroxyprogesterone Acetate in Serum and Milk in Lactating Woman Who Used Depo Geston(R)

The Disease-Modifying Effect of Dehydroepiandrosterone in Different Stages of Experimentally Induced Osteoarthritis: a Histomorphometric Study

Effect of Injection of Testosterone Undecanoate and Depot Medroxyprogesterone Acetate on the Suppression of Spermatogenesis

The Effect of Depo Medroxyprogesterone Acetate (DMPA) on Cerebral Food Motivation Centers: A Pilot Study Using Functional Magnetic Resonance Imaging.

A dose-response and meta-analysis of dehydroepiandrosterone (DHEA) supplementation on testosterone levels: perinatal prediction of randomized clinical trials

A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA supplementation of bone mineral density in healthy adults.

The Effects of Er Xian Decoction Combined with Baduanjin Exercise on Bone Mineral Density, Lower Limb Balance Function, and Mental Health in Women with Postmenopausal Osteoporosis: A Randomized Controlled Trial

Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial

Effects of dehydroepiandrosterone on in vitro cultured osteoblasts and osteoprotegerin in rats

The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency

Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women. III. Medroxyprogesterone acetate

Effect of Dehydroepiandrosterone on Rat Osteoblasts in Vitro